Nakano I, Fukuda Y, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Kumada T, Nakano S
Second Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Japan.
Gut. 2001 Aug;49(2):263-7. doi: 10.1136/gut.49.2.263.
Genotype 1b of hepatitis C virus (HCV) comprises mainly three subtypes, each named for its geographic prevalence (worldwide, W; Japan, J; and not in Japan, NJ).
To characterise the newly identified subtypes of genotype 1b and to review factors associated with response to interferon (IFN) for each subtype.
Chronic hepatitis patients (80 men and 41 women; mean age 48.5 years, range 20.7--69.3) with HCV genotype 1b (W type, n=41; J type, n=38) or genotype 2a (n=42) were treated according to the same IFN protocol. Forty four patients (36.4%) negative for serum HCV RNA six months after cessation of treatment were considered complete responders.
Factors associated with complete response were investigated.
Genotype 2a patients had lower viral loads (odds ratio 0.11 (95% confidence intervals (CI) 0.049--0.256)) and a better IFN response (odds ratio 0.25 (95% CI 0.117--0.552)) than genotype 1b patients whereas W type and J type patients had similar viral loads and responses to IFN. IFN response in W type patients was associated with female sex (odds ratio 0.23 (95% CI 0.055--0.983)) and low viral load (odds ratio 84.00 (95% CI 14.04--502.6)) whereas response in J type patients was related to transfusion history (odds ratio 7.20 (95% CI 1.443--35.91)), low viral load (odds ratio 117.0 (95% CI 17.82--768.3)), and genetic mutation in the interferon sensitivity determining region of the virus (odds ratio 0.08 (95% CI 0.013--0.553)). Multivariate analysis found low viral load (odds ratio 64.19 (95% CI 14.66--281.06)) to be the only significant independent factor associated with IFN response.
Factors associated with IFN responsiveness in HCV infection differ with viral subtype.
丙型肝炎病毒(HCV)1b型主要包括三个亚型,每个亚型根据其在全球的流行情况命名(全球型,W;日本型,J;非日本型,NJ)。
对新发现的1b型亚型进行特征分析,并回顾各亚型与干扰素(IFN)反应相关的因素。
慢性肝炎患者(80名男性和41名女性;平均年龄48.5岁,范围20.7 - 69.3岁),HCV 1b型(W型,n = 41;J型,n = 38)或2a型(n = 42),按照相同的IFN方案进行治疗。治疗停止6个月后血清HCV RNA阴性的44名患者(36.4%)被视为完全应答者。
研究与完全应答相关的因素。
与1b型患者相比,2a型患者病毒载量较低(优势比0.11(95%置信区间(CI)0.049 - 0.256))且IFN反应较好(优势比0.25(95%CI 0.117 - 0.552)),而W型和J型患者病毒载量及对IFN的反应相似。W型患者的IFN反应与女性性别(优势比0.23(95%CI 0.055 - 0.983))和低病毒载量(优势比84.00(95%CI 14.04 - 502.6))相关,而J型患者的反应与输血史(优势比7.20(95%CI 1.443 - 35.91))、低病毒载量(优势比117.0(95%CI 17.82 - 768.3))以及病毒干扰素敏感性决定区的基因突变(优势比0.08(95%CI 0.013 - 0.553))有关。多因素分析发现低病毒载量(优势比64.19(95%CI 14.66 - 281.06))是与IFN反应相关的唯一显著独立因素。
HCV感染中与IFN反应性相关的因素因病毒亚型而异。